Intimation of the Credit Ratings assigned by CARE Ratings Limited.

Evonile Pharma Limited (formerly known as Novartis India Limited) October 07, 2026 BSE Limited The Secretary, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. BSE Scrip Code: 500672 Subject: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) regarding the New Credit Rating obtained from CARE Ratings Limited. Dear Sir/Madam, Pursuant to Regulation 30 read with Clause 3 of Para A of Part A of Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that CARE Ratings Limited has assigned credit ratings to the Company's bank facilities on October 07, 2026. The details of the credit ratings assigned are as follows: Credit Rating Agency Facilities Rating Assigned CARE Ratings Limited Long Term Bank Facilities CARE A; Stable Long Term / Short Term CARE A; Stable / CARE A2+ Bank Facilities The rating rationale issued by CARE Ratings Limited shall be available on its website. The aforesaid information is also being made available on the Company's website at www.nilpharma.co.in. Kindly take the above information on record. Thank you. For Evonile Pharma Limited (Formerly known as Novartis India Limited) Chandni Maru Company Secretary and Compliance Officer M. No. A60291 Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in